These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 6041224)

  • 1. [Syndrome of "open cavity healing". (Analysis of late results of treatment)].
    Zierski M
    Gruzlica; 1967 Mar; 35(3):219-26. PubMed ID: 6041224
    [No Abstract]   [Full Text] [Related]  

  • 2. [Early and late results of treatment of patients with tuberculosis shedding mycobacteria with primary resistance to basic antituberculous drugs].
    Dubrawska H; Gryziecka T; Maceluch-Wojtkowa M; Orzechowska W
    Wiad Lek; 1968 Jan; 21(2):77-80. PubMed ID: 5671874
    [No Abstract]   [Full Text] [Related]  

  • 3. [Symposium on the open negative syndrome. 2. Formation of the open negative cavity during the course of original treatment and the fate of the cavity].
    Miyagi Y
    Kekkaku; 1966 Aug; 41(8):375-8. PubMed ID: 5975303
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of treatment of pulmonary tuberculosis in aged patients (after 6-years of observation)].
    Smaga M; Cyganiewicz E; Mysakowska H
    Gruzlica; 1967; 35(11):1181-6. PubMed ID: 6063622
    [No Abstract]   [Full Text] [Related]  

  • 5. [Causes of ineffective treatment of newly detected pulmonary tuberculosis].
    Borshtenbinder IV; Smirnov GA
    Probl Tuberk; 1978 Oct; (10):33-6. PubMed ID: 714904
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of antibacterial treatment of pulmonary tuberculosis in patients with primary resistance to drugs].
    Mysakowska H; Pietroń E; Sikora-Rózyńska M; Smaga M; Litwin B; Rybicka-Stryjecka Z
    Pol Tyg Lek; 1965 May; 20(19):686-8. PubMed ID: 5844021
    [No Abstract]   [Full Text] [Related]  

  • 7. [Symposium on the open negative syndrome. 5. Studies on the open negative syndrome occurring after chemotherapy with secondary antituberculous drugs].
    Kimura Y
    Kekkaku; 1966 Aug; 41(8):383-6. PubMed ID: 5975306
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fate of patients with pulmonary tuberculosis and secondary drug resistance to the major drugs].
    Kost A
    Gruzlica; 1969 Nov; 37(11):997-1002. PubMed ID: 5368630
    [No Abstract]   [Full Text] [Related]  

  • 9. [Symposium on the open negative syndrome. 4. Study on the prognosis of the open negative syndrome occurring after chemotherapy with primary anti-tuberculous drugs].
    Fujioka M; Yoshida F; Komoto H; Takahashi O; Nishiyama K
    Kekkaku; 1966 Aug; 41(8):381-3. PubMed ID: 5975305
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of treatment in new cases of pulmonary tuberculosis registered in 1963 at the Antitubercular Dispensary of the Wola District of Warsaw].
    Rose A
    Gruzlica; 1967 Dec; 35(12):1251-6. PubMed ID: 6081907
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of the treatment in patients with pulmonary tuberculosis excreting bacilli in primary resistance to antitubercular drugs].
    Hornung S; Polończyk M
    Gruzlica; 1965 Oct; 33(10):886-9. PubMed ID: 5881604
    [No Abstract]   [Full Text] [Related]  

  • 12. [Research on primary resistance to antitubercular agents and antibiotics in the antituberculosis centers].
    Santi GM; Poggiopollini M
    Minerva Med; 1967 Jun; 58(49):2285-8. PubMed ID: 6029301
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparison of late results of treatment of patients operated on for pulmonary tuberculosis and those refusing surgery].
    Jaworski J
    Gruzlica; 1971 Sep; 39(9):905-12. PubMed ID: 5111367
    [No Abstract]   [Full Text] [Related]  

  • 14. [New aspects in the control and treatment of chronic pulmonary tuberculosis].
    Milutinović R; Zigić M; Ilić M
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():79-86. PubMed ID: 4614297
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pulmonary tuberculosis and primary bacterial resistance to antibacillary drugs].
    Cazes M
    Torax; 1967 Dec; 16(4):222-30. PubMed ID: 5620686
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the prognosis of cases with open negative cavity developing mainly due to therapy with primary antituberculosis drugs.
    Fujioka K; Yoshida F; Kawamoto H; Takahashi O; Nishiyama K; Hidaka O
    Jpn J Tuberc; 1966 Dec; 13():Suppl:65-70. PubMed ID: 5298481
    [No Abstract]   [Full Text] [Related]  

  • 17. [Specific serum antimycobacterial activity test in pulmonary tuberculosis patients].
    Yamagata Y; Konomata T
    Iryo; 1966 May; 20(5):450-5. PubMed ID: 5963052
    [No Abstract]   [Full Text] [Related]  

  • 18. "Open-negative" syndrome. Clinical course of its development and subsequent destiny.
    Miyagi Y
    Jpn J Tuberc; 1966 Dec; 13():Suppl:54-9. PubMed ID: 5298479
    [No Abstract]   [Full Text] [Related]  

  • 19. [Primary resistance to major antitubercular drugs in patients with recently discovered pulmonary tuberculosis in the yea.s 1961-1969].
    Zduńczyk-Pawelek H; Antosiewicz A; Blitek-Golc D
    Gruzlica; 1971 Feb; 39(2):89-93. PubMed ID: 5551351
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment results with patients with destructive pulmonary tuberculosis and their late follow-ups].
    Kalabukha AV; Kalabukha VA
    Vrach Delo; 1985 Jul; (7):41-2. PubMed ID: 4049824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.